198 related articles for article (PubMed ID: 31014368)
1. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
Chang WH; Lai AG
J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
[TBL] [Abstract][Full Text] [Related]
2. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
3. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
4. Cancer clocks in tumourigenesis: the p53 pathway and beyond.
Stephenson EM; Usselmann LEJ; Tergaonkar V; Virshup DM; Dallmann R
Endocr Relat Cancer; 2021 Apr; 28(4):R95-R110. PubMed ID: 33638942
[TBL] [Abstract][Full Text] [Related]
5. The circadian clock in cancer development and therapy.
Fu L; Kettner NM
Prog Mol Biol Transl Sci; 2013; 119():221-82. PubMed ID: 23899600
[TBL] [Abstract][Full Text] [Related]
6. Circadian regulation of cancer cell and tumor microenvironment crosstalk.
Xuan W; Khan F; James CD; Heimberger AB; Lesniak MS; Chen P
Trends Cell Biol; 2021 Nov; 31(11):940-950. PubMed ID: 34272133
[TBL] [Abstract][Full Text] [Related]
7. The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
Pourali G; Ahmadzade AM; Arastonejad M; Pourali R; Kazemi D; Ghasemirad H; Khazaei M; Fiuji H; Nassiri M; Hassanian SM; Ferns GA; Avan A
Mol Cell Biochem; 2024 May; 479(5):1243-1255. PubMed ID: 37405534
[TBL] [Abstract][Full Text] [Related]
8. The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy.
Zhu H; Chen J; Wen Z; Li J; Yu Q; Liao W; Luo X
Life Sci; 2023 Nov; 333():122145. PubMed ID: 37797685
[TBL] [Abstract][Full Text] [Related]
9. TimeTeller: A tool to probe the circadian clock as a multigene dynamical system.
Vlachou D; Veretennikova M; Usselmann L; Vasilyev V; Ott S; Bjarnason GA; Dallmann R; Levi F; Rand DA
PLoS Comput Biol; 2024 Feb; 20(2):e1011779. PubMed ID: 38422117
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Implications of Circadian-HIF Crosstalk.
Peek CB
Trends Endocrinol Metab; 2020 Jun; 31(6):459-468. PubMed ID: 32396846
[TBL] [Abstract][Full Text] [Related]
11. Divergent mutational processes distinguish hypoxic and normoxic tumours.
Bhandari V; Li CH; Bristow RG; Boutros PC;
Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas.
Shen H; Cook K; Gee HE; Hau E
J Exp Clin Cancer Res; 2020 Jul; 39(1):129. PubMed ID: 32631383
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal Control of the Circadian Clock and Cellular Redox State - a Critical Appraisal.
Putker M; O'Neill JS
Mol Cells; 2016 Jan; 39(1):6-19. PubMed ID: 26810072
[TBL] [Abstract][Full Text] [Related]
14. Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis.
Pérez-Villa A; Echeverría-Garcés G; Ramos-Medina MJ; Prathap L; Martínez-López M; Ramírez-Sánchez D; García-Cárdenas JM; Armendáriz-Castillo I; Guerrero S; Paz C; López-Cortés A
Sci Rep; 2023 Aug; 13(1):14198. PubMed ID: 37648722
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock.
Nelson N; Relógio A
NPJ Precis Oncol; 2024 Feb; 8(1):40. PubMed ID: 38378853
[TBL] [Abstract][Full Text] [Related]
16. Circadian effects on UV-induced damage and mutations.
Goodenow D; Greer AJ; Cone SJ; Gaddameedhi S
Mutat Res Rev Mutat Res; 2022; 789():108413. PubMed ID: 35690416
[TBL] [Abstract][Full Text] [Related]
17. The circadian clock circuitry deconvolutes colorectal cancer and lung adenocarcinoma heterogeneity in a dynamic time-related framework.
Melocchi V; Cuttano R; Murgo E; Mazzoccoli G; Bianchi F
Cancer Gene Ther; 2023 Oct; 30(10):1323-1329. PubMed ID: 37479798
[TBL] [Abstract][Full Text] [Related]
18. Circadian Clock and Hypoxia.
Sartor F; Ferrero-Bordera B; Haspel J; Sperandio M; Holloway PM; Merrow M
Circ Res; 2024 Mar; 134(6):618-634. PubMed ID: 38484033
[TBL] [Abstract][Full Text] [Related]
19. The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
Murgo E; De Santis E; Sansico F; Melocchi V; Colangelo T; Padovano C; Colucci M; Carbone A; Totti B; Basti A; Gottschlich L; Relogio A; Capitanio N; Bianchi F; Mazzoccoli G; Giambra V
J Exp Clin Cancer Res; 2023 Aug; 42(1):218. PubMed ID: 37620852
[TBL] [Abstract][Full Text] [Related]
20. Combined transcriptome and proteome profiling reveals specific molecular brain signatures for sex, maturation and circalunar clock phase.
Schenk S; Bannister SC; Sedlazeck FJ; Anrather D; Minh BQ; Bileck A; Hartl M; von Haeseler A; Gerner C; Raible F; Tessmar-Raible K
Elife; 2019 Feb; 8():. PubMed ID: 30767890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
